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Repeat coronary angiography was pwforad in 41 patients 
lOyearrafterrandomizntiontom~!ic~ltn = 2l)orsurgtcal 
(n = 21) therapy for chronic anginn. The native coronary 
arteries were cladRed inlo 15 an&graphic segments and 
3 arterial truntis for analysis of progression of coronary 
artery disease. 
arteries proximal (84%) to the anastomosir than in arteries 
distal (16%) to graft insertion (P < 0.0011. plcwesslon 
acrurmd 10 46% of proximal segments compared with 23% 
al distal segments (p C 0.02). Pmgression wer wen In 23 
(55%)of43 scgmeatswitb an occluded graft compared with 
30 (31%) of 96 segments wltb a patent graft ,p < 0.02). 
The incidence rate of disease progrersian in roronsry 
segmrnls was 24% and 28% in medically and surgkally 
treated patieotr, respoctiwly (p :: NS). Grafted segments 
showed a 38% rsto 01 disease progression, which was 
higher than the 18% rate for omgraft~d segments (p < 
0.001) and the overall rate of 21% for medically treated 
patients (p < 0.01). Simllrirly. 29 (94%) of 3i gratled 
arteriw exhibited disease progrrsrion compared witb 19 
(59%) 0132 mangrafted srterles i9 < 0.01) and 42 (67%) of 
63 arteries in medically Irested padents (p < 0.01). In 
wfted vessels, disease progrksslon occurred more oftea in 
Ten years atIer randomimtlon, medlwdty and sur@zdly 
treated patients showed a comparabie rnte ofdiwaae pro- 
gression in coronary segments. However, surgical therapy 
potiooa. Occluded grafts also correlated with 80 adverse 
effect on disease progression. Tbrse longarm effects 
rhmdd be taken into conrideralion when aortocorooary 
bypas surgery Is cimtamptated. 
(3 Am Coil Cardioi 1990;16:1066-70) 
Coronary artery revascularization plays an important role in 
the management of patients with coronary artery disease and 
has been shown to reduce symptoms. improve left ventric- 
ular fur&inn and prolong life in selected patient groups 
(l-4). It also has cw!lnd some controversies (5-7). one of 
which concerns the effect of bypa surgery on the pmgres- 
sion of coronary athemsclemsis in nawe comnary vessels. 
Ketrospective studie. (S-14) have shown that coronary 
revascularization causes an increase in the progression of 
native coronary artery disease, especially in the segment 
proximal to the site of the bypass amwomosis. However, in 
our prospective randomized study (IS) of - .~~.al versus 
surgical therapy, we found no independent effect of bypass 
surgery on progression ofcoronary atherosclerosis at 5 years 
after randomization. Because 42 of the patients originally 
randomized have had $1 Id year follow-up angiogran, we 
now update and extend our observations. 
Methods 
Study patients. Between 1970 ;md 1974,148 patients with 
chronic stable angina who underwent cardiac catheterization 
and coronary angiography at our institutions, were found to 
have surgically bypassable comnaiy artery disease and 
agreed to participa’e in the Veterans Adminismdion Coop 
erative Study ilf rredical versus surgical therapy in patients 
pith chronic a,table coronary artery disease (16). This study 
randomly assigned patients to medical or surgical treatment 
after they pmvided informed written consent. The study was 
approved by the local institutional review board and the 
cooperative study committee. As part of !he study protocol. 
patieo’r wre requested to undergo repeat coronary arteri- 
ography 5 and IO years after randomization regardless of 
their symptoms. Before each aogiagraphic procedure. par- 
ticipating patients signed the study cotwent form in addition 
to the iostitutional cotwent form. 
Forty-one of 77 medically treated and 49 of 71 surgically 
treated patients survived 28 years and wete eligible for IO 
year foilow-up angiography. Twenty-one medically trrat:d 
and 21 surgical!y treated patients had repeat coronary artc- 
riograms at intervals of I21 i I6 and II6 2 I6 mouths, 
respectively. after mndomizo!ion. Twenty-sin patients (I? 
medically treated and I4 surgically trt ated patients) had both 
S and 10 year studies. The prenndc~mization clinical char- 
ac:eristics for all patients who had ?tJ year follow-up angi- 
ography are shown in Table 1. 
Coronary anglegraphy. In addition to selective angiogra- 
phy of nattve coronary &eries in all patients. aortocoronary 
bypws grafts were studied in patients wuh vein grafts. 
Arttriograna wete viswtd mJcp~uc,t~;y by :~o _.LI SF 
and stenoses w re anked utilizing a sin point graaing system 
previously used in our institution (15). To facilitete a rtan- 
dardized analysis of coronary arteriograms. the coronary 
artery, tree was divided into I5 segotems (Fig. I) and 3 major 
coronary arteries (15). To reduce observer variability in 
grading, the baseline and IO year studies for each patient 
were viewed simultaneously so that the two studies could be 
compared by using stmiler anglographic projections (17). in 
patients who had baseline. 5 war and IO vear studies. !hree 
&iograots would be viewved~in similar fashion for compar- 
ison. Two experienced angiographcrs independently graded 
each angiogram. and discrepancies in grading were resolved 
during joint review. 
As we previously reported ti5). progression of the dis- 
ease in a coronary segmeot was defined as an increase of at 
least one g,adc of preexisting stenosis or the appearance of 
a ue.v _-5OG stenosis in a segment that exhtbited no &ase 
on the baseline angiogram. A segment was considered 
grafted if tt received or was perfused by a graft. For 
example. if segment IO had a critical steuo& and a graft was 
placed to the middle ofsegment I?. then segments I I. I?. 13 
and I4 were considered grafted (Fig. I). Segments I I, I3 and 
I4 and the proximal portion of segment I2 were also consid- 
ered proxrmal segments: the distal portion of segment I? was 
considered the distal segment. Likew&, tne proximai artery 
included segments I I, I3 and I4 and the proximal portion of 
segment I?: the distal artery was considered the distal 
portion of segment I2 
Statistics. Statistical analysis was performed using the 
chi-x&we telt. A p *value <O.fJS was considered significant. 
Results 
Progression of diseax in native coronary arteries between 
?dselirte and 10 years. Disease progression occurred in 70 
124%) of 286 segments in medically treated patients and 81 
IZH%J of 292 segments in surgically treated patients at the IO 
year follow-up study (p = NS). In 26 patients (I2 medically 
and I4 surgically treated) having both 5 and IO year studies. 
89 (25%) of 392 segments demonstrated significant prcgzs- 
sio,, at the 10 year observation. However, 70 (89%) of these 
89 segments had already shown progression at the 5 year 
study. 
The incidence of progression of disease in segments 
initiallv free of disease was similar in the medical and 
surgic~! groups: 33 (18%) of I81 segments and 34 (17%) of 
203 segments, respectively, at 10 years. However. in the 
segments that already bad evidence of disease, 47 (53%) of 
89 segments in the surgical group showed progression com- 
pared with 37 (35%) of 105 segments in the medical group (p 
< 0.05) (Fig. 2). 
When the incidence of disease progression in major 
coronary arteries was compared, no significant difference 
was found (67% in the medical group and 76% in the surgical 
group) (Table 2). In the medical group, the incidence of 
progression of diseased major coronary arteries was higher 
than in the disease-free arteries, but this ditkrcncc did not 
reach statistical significance as a result of a small number of 
disease-free arteries (Table 2). 
Effect of grafting an disease progression. At IO years. 38% 
of grafted segments sbowcd progression of disease; this rate 
was significantly greater than the 18% rate of nongrafted 
segments (p < O.OOi) and the overall 24% progression rate in 
the medically treated group (p < 0.01) (Fig. 3). Similarly, 
Grafted NonCra‘ted 
@we 3. Percent of grafted and nongrafwd segments with disease 
progression at IO years. 
94% of the grafted major coronary arteries displayed disease 
progression. which was a significantly greater incidence 
compared with the 5% rate incidence in nongrafted arteries 
(p < 0.01) and the 67% incidence rate in major coronary 
arteries in medically treated patients (p < 0.01) (Table 2). 
Furthermore, 26 (84%) of 31 arteries proximal to the anas- 
tomosis exhibited disease progression compared with 5 
(16%) of 31 distal arteries (p < 0.001). Also, 42 (46%) of 91 
proximal segments and II (23%) of 47 distal ~egtnents 
showed disease progression (p < 0.02). 
E&t of gmR patency on disease progression. In the 21 
surgically treated patients. 41 saphenous vein grafts were 
implanted; I5 grafts were occluded and 26 grafts were patent 
at the IO year study. Progression of disease occurred in 23 
(55%) of the 42 grafted segments thought to be supplied by 
an occluded graft, but in only 30 (31%) of 96 grafted 
segments supplied by a patent graft (p < 0.02) (Table 3). 
Discussion 
As we stated, a better designed study determining the 
effect of saphenau? vein graft aortocoronwy bypass surgery 
on the progression of native coronary artery disease would 
include randomization into medical and surgical groups after 
an initial an&graphic evaluation and with repeat corcmaty 
angiography performed at prcdctcmkted intervals rcgard- 
less of the patient’s symptomatic status (15). This type of 
clinical trial would avoid the problems encountered in com- 
paring well defined critical proximal stcno~es with variable 
characrerisrics of the dwal segments (9.10.131 and the prob- 
lem of varying late> of d&ease progression for dlifereni 
degrees of stenosis (18-21). In 1981. we reported ,151 the j 
year results of such a clinical trial and now swnd our 
obsmwtions to IO years afler msdomzation. By comparmg 
the 5 and IO year results. we grain insight into the long-term 
influence of aortocoronary bypw vx8ery on natwe core. 
nary artery discase progression. 
Progression of coronary artery disease. At the 10 yex 
follow-up study, 24% and 28% of the segment\ in medically 
and surgically treated patients. respecttrely. exhtblted dw 
ease progression; these Incidence rates did not differ Ggmf- 
icantiy from the 22% and 23% rates observed at the 5 year 
study (IS). Furthermore, in 26 patzents having both 5 and IO 
year studies. 89% of segments demonstrming Ggmficant 
disease progression at 10 years had already shown pro8rw 
sion at 5 years. Thus. it appears that the progression of 
native coronary artery disease peaks in the I to 5 year pe tod 
and levels oiiin the 6 to 10 year period. 
That the originally diseased segment bad a sigmfir‘antly 
greater incidence of disease progression compared with the 
disease-free segment in both the medically iod wgiially 
treated patients was documented at both the 5 115) and IO 
year studies. The same results were also sh.wn at both tome 
periods when diseased versus ditease-free arteries in medt- 
ally treated patients and grafted versus nongrafted vessels 
in surgically treated patients were compared (lS.Z?l. The 
obsetvatiou that coronary atherosclerosis progresses more 
uften to the diseased vessel is consistent with many o!her 
repats (9-12.22). 
E&l of grsNing on progression. At the 5 year angio- 
graphic study, the incidence of disease progression in grafted 
and nongrafted segments was 24% and 22%. respectively, in 
the surgically treated patients; these rates did not differ from 
rhe 22% overall rate of disease progression in the medically 
treated patients. However, at IO years. the incidence of 
disease wxression accelerated to 38% in crafted seemems 
compared with the 18% incidence rate ihnongraft~d seg- 
ments f~ < 0.0011 and the 24% overall rate of disease 
progression in medically treated patients (p < 0.01) (Fig. 3). 
The same observation was VW for the rate of disease 
progression in grafted wsus nongrafted srteries in sure’ 
tally treated patients (Table 2). In contrast. we did not notice 
a significant increase in the incidence of vrwression in 
diseased segments at 5 and IO yeari (32% at 5 years verw 
35% fd IO yean) and in the disease-free secments (16% at 5 
years v&s 18% at IO years) in medic&treated palien!s. 
Therefwe, ao”owro”ary bypass sorgery wtth R ~a!>hmrw 
vein graft accelerates the progression of native coronary 
artery disease (8-14.22). 
Several nonrandomized clinical tria!, (8-14) and one large 
randomized study 122) reported that aortocoronary bypss 
surgery accelerated coronary dtherosc!crusis proximal to the 
insertion sites of grafts during the ISI 5 years. especially in 
rix lit year Zfter that. grafted and nonuaftcd ve~els 
u\uJly CT’ ihlted the same rate of disease progression. In 
thl\ randomucd trial. we showed that the grafted wmcnt\ 
have :I greater iradence of progrenion-compares wnb 
nongnllcd qment> or segments from medically treated 
patienrr evident at 10 years bur not a! ? years after random- 
IliLt,““. 
.A! the /O vesr follow-up e\aIom:on. we confirmed a 
greater mcldcncc of decease progression in grafted than in 
nongrafted arw its (15.22.?31 and the predominant OCCUT- 
rence oi progrnsion tn the artery proximal to the anastomo- 
\I\ (X-12.?!). The marked acceleration of native coronary 
artery d~\e:~ru in the proximal portion of the grafted vessel 
dung the I\1 year after surgery may be explained by blood 
rtxis rcwlting from compewion betueen native and bypss\ 
conduit, tX.9.!+.?5l. However, we cannot fully explain 
dtvxae progrclsion in the natwe coronary artery up to IO 
year> after aortocoronary bypass surgery. 
E&t of graR patency on progression. Thirty-seven per- 
cent of vein grafts were occluded and another 30% 10 40% of 
grafls had xgnificant atheroscierosis. especially in patients 
with abnormal lipid levels. 5 and IO years after surgery 
tIO.?6.?7). At the 5 year study. we reported (15) that 
coronary artery disease progressed in 20% to 25% of seg- 
mats regardlrrs of the patency of the saphenaos vein prafts. 
Kroncke et id. (22) also showed that the bypass graft (open 
or closed) + ar associated with an increased odds ratio for 
prosesGun of coronary artery disease. In this IO year 
follow-up ctudy. segments in the region thought to be 
suodied by ao occluded craft had a h&her incidence of 
did&se prbgression than that of segme& supplied by a 
patent gnf!. This observation deserves further confirmation. 
Clinical implications. From this prospective randomized 
study of medical versus surgical therapy for patients with 
chronic stable angina and coronary artery disease treated 
with bypass graft surgery, we observed that the overall 
incidence of progression of native coronary atherosclerosis 
is similar for the 5 and IO year studies in both groups. 
-;:o~.,w wrgical therapy with saphenous vein grafts at IO 
years causes a higher incidence of disease progression in 
native coronary arteries proximal to insertion of the graft 
regardless of its patency. These effects should be taken inlo 
considcrmion when aonocoronary bypass surgery is con- 
templated. 
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